Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON)

158 filings reported holding IRON - Disc Medicine, Inc. - Common Stock, $0.0001 par value per share as of Q1 2024.
Disc Medicine, Inc. - Common Stock, $0.0001 par value per share (IRON) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 22.2M shares of 35M outstanding shares and own 63.33% of the company stock.
Largest 10 shareholders include Paradigm Biocapital Advisors LP (2.39M shares), Atlas Venture Life Science Advisors, LLC (2.29M shares), ORBIMED ADVISORS LLC (1.7M shares), Bain Capital Life Sciences Investors, LLC (1.32M shares), STATE STREET CORP (1.09M shares), PRICE T ROWE ASSOCIATES INC /MD/ (944K shares), PERCEPTIVE ADVISORS LLC (940K shares), BlackRock Inc. (902K shares), Frazier Life Sciences Management, L.P. (785K shares), and VANGUARD GROUP INC (783K shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.